Background & Aims The increasing rates of obesity and type 2 diabetes mellitus may lead to
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …

Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …

Despite tremendous research advancements in nonalcoholic fatty liver disease (NAFLD),
our understanding of sex differences in NAFLD remains insufficient. This review summarizes …

As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence
of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

NAFLD is one of the most important causes of liver disease worldwide and will probably
emerge as the leading cause of end-stage liver disease in the coming decades, with the …

The increase in Non‐alcoholic Fatty Liver Disease (NAFLD) and the imminent
disappearance of chronic viral hepatitis thanks to new and effective therapies is motivating …

Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatis, cirrhosis, and hepatocellular carcinoma (HCC) associated with striking …

Cigarette smoking is a preventable risk factor for premature morbidity and mortality. A history
of smoking is observed in approximately 40% of patients with liver disease, while a growing …

This Review presents current epidemiological trends of the most common liver diseases in
Asia–Pacific countries. Hepatitis B virus (HBV) remains the primary cause of cirrhosis; …